Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | REV1 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
mRNA | FGL2 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
mRNA | ADRB1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.05 |
mRNA | RPP25 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.05 |
mRNA | FUT2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.05 |
mRNA | DYRK2 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
mRNA | NUTM2B | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
mRNA | SYNCRIP | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
mRNA | CPSF6 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.05 |
mRNA | CXXC5 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |